Samplix is a Danish biotech company with proprietary technologies for NGS and digital PCR. Samplix` patented technologies are based on an advanced microfluidics system, that can produce millions of emulsion droplets, making genetic analyses more effective. Samplix` technologies enable analyses of structural variants that are not possible with today’s technologies. The system also applies for digital PCR analysis of mutations, including liquid biopsies.
Samplix is working with world-leading institutions and companies in the development of instruments and consumables for DNA enrichment and applications testing in the fields of cancer, immunology, and epidemiology